New Methods Reduced Pain During IUD Insertion
Researchers confirmed that medical interventions can effectively lower discomfort for patients undergoing IUD procedures.
Updated on Oct. 7, 2026 in Sex Life
Live Poll
Should doctors prioritize more extensive pain relief options during routine gynecological procedures?
Recent studies have identified effective methods to reduce pain during IUD insertion, addressing a primary barrier for patients considering the contraceptive. Findings from clinics in Massachusetts and research in Sweden highlight potential strategies for managing procedural discomfort.
Why it matters
Concerns regarding pain levels during IUD insertion frequently influence a patient's decision to utilize or avoid the contraceptive method. By identifying effective pain management techniques, healthcare providers can improve patient experiences and access to long-term birth control.
A study of 370 participants showed mepivacaine reduced mean pain scores to 43.8 mm, compared to 58.6 mm for the placebo group. Separately, 20.3% of 1,324 patients in a Massachusetts clinic study received intravenous sedation.
The players
Swedish researchers
These investigators led a study involving 370 participants to evaluate the effectiveness of local anesthesia during contraceptive procedures.
The details
Swedish researchers found that administering 10 mL of mepivacaine via a hydrosonography catheter 2 minutes before insertion significantly decreased patient discomfort. Meanwhile, clinics in Massachusetts have begun offering intravenous sedation using fentanyl and midazolam, particularly for patients who have never given birth.
Timeline
April 1, 2024 to March 30, 2025: Massachusetts study period for IUD pain management.
2024: Swedish study on mepivacaine effectiveness published.
2027: Planned revision of the S2k Guideline on Non-Hormonal Contraception.
Culture Shift
These findings align with evolving patient-centered care models that prioritize comfort, challenging the historical norm of minimizing procedural pain. As clinical evidence grows, it directly influences the 2024 S2k Guideline on Non-Hormonal Contraception, which is scheduled for revision in 2027.
Patients may find that requesting specific pain management options, such as local anesthesia or sedation, leads to a more comfortable and manageable IUD insertion experience. Individuals should consult with their healthcare provider about which methods are currently offered at their clinic.
The takeaway
Advancements in pain mitigation can help remove significant barriers for individuals seeking long-term contraceptive options. Patients should feel empowered to discuss their comfort requirements and available pain relief protocols during their initial consultation.
What happens next
The S2k Guideline on Non-Hormonal Contraception is scheduled for a comprehensive revision in 2027.
Further reading
For more information on contraceptive choices and reproductive health, visit our Sex Life section.
Source note: This article includes information reported by Medscape.
Live Poll
Should doctors prioritize more extensive pain relief options during routine gynecological procedures?
